Thom, S., Poulter, N., Field, J., Patel, A., Prabhakaran, D., Stanton, A., Grobbee, D.E., Bots, M.L., Reddy, K.S., Cidambi, R., Bompoint, S., Billot, L. and Rodgers, A. (2013) Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients with or at High Risk of CVD: The UMPIRE Randomized Clinical Trial. JAMA, 310, 918-929.
http://dx.doi.org/10.1001/jama.2013.277064

has been cited by the following article:

• TITLE: Prevalence and Characteristics of Treatment-Resistant Hypertension among Hypertensive Japanese Outpatients

  AUTHORS: Keisuke Okamura, Hidenori Urata

  KEYWORDS: Treatment-Resistant Hypertension, Catheter-Based Renal Sympathetic Denervation, Human

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.9, September 10, 2015

  ABSTRACT: Aims: To retrospectively investigate the prevalence and characteristics of treatment-resistant hypertension (R-HT) among consecutive hypertensive outpatients, since patients with R-HT are candidates for catheter-based renal sympathetic denervation (RD). Methods: Consecutive hypertensive outpatients (n = 999) were recruited in our hospital. R-HT patients who were candidates for RD had clinic systolic blood pressure > 160 mmHg despite taking three or more antihypertensive drugs including at least one diuretics at higher than standard doses. Results: Our survey indicated that only 26 patients (2.6%) were potential candidates for renal denervation. Candidates for RD showed a significantly higher age (P